๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma

โœ Scribed by Iacopo Petrini; Monica Lencioni; Miriam Ricasoli; Mauro Iannopollo; Cinzia Orlandini; Filippo Oliveri; Carlo Bartolozzi; Sergio Ricci


Book ID
105993785
Publisher
Springer
Year
2011
Tongue
English
Weight
261 KB
Volume
69
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A phase II trial of gemcitabine in patie
โœ Charles S. Fuchs; Jeffrey W. Clark; David P. Ryan; Mathew H. Kulke; Haesook Kim; ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 74 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND There is no effective systemic therapy for patients with hepatocellular carcinoma. A recent trial reported a moderate antitumor activity for gemcitabine among Asian patients with advanced hepatocellular carcinoma. This led to our examination of the efficacy and tolerabili

A Phase II trial of nolatrexed dihydroch
โœ Keith Stuart; Judy Tessitore; Jeff Rudy; Neil Clendennin; Amanda Johnston ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 70 KB ๐Ÿ‘ 2 views

## BACKGROUND. Inoperable hepatocellular carcinoma is an incurable malignancy with no accepted standard therapy. Chemotherapy has demonstrated occasional responses and the need is great for a new and effective agent. Therefore the authors conducted this Phase II trial of a novel thymidylate syntha